ReviewSurgical endoscopy2026
Robotic thyroidectomy using the da Vinci SP surgical system.
Review in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Single-port, via a midline approach, Robotic Transaxillary Thyroidectomy (SMART-Thyroidectomy): description of the technique and evaluation of feasibility in the first case series.Journal of robotic surgery · 2026Article
- Single-port robotic areolar thyroidectomy: technical feasibility and clinical outcomes of 64 consecutive cases.Journal of robotic surgery · 2026Article
- Robotic-assisted parotidectomy as a remote-access alternative to conventional open surgery: a single-center comparative experience.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Single-port robotic areolar surgery for thyroid and neck procedures: a 3-year, 500-case single-surgeon experience using the da-Vinci SP system.Updates in surgery · 2026Article
- Not all patients need a robot: comparative perioperative outcomes of robotic BABA versus endoscopic CABBA thyroid lobectomy with ipsilateral central lymph node dissection, stratified by body mass index.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to summarize the current clinical evidence, technical advances, and practical insights related to robotic thyroidectomy using the da Vinci SP (Single-Port) surgical system, with an emphasis on the evolution of surgical approaches and outcomes based on the author's institutional experience and literature review.
methodsA focused narrative review of studies published between 2019 and 2025 was conducted to evaluate the safety, feasibility, and clinical performance of single-port robotic thyroidectomy. Five representative SP approaches (single-port transoral robotic thyroidectomy [SP-TORT], single-port transaxillary robotic thyroidectomy [SP-TART/START], retroauricular approach using the da Vinci SP system [RA-SP], single-port robotic areolar approach [SPRA], and gas-insufflation one-step single-port transaxillary [GOSTA]) were compared in terms of operative technique, ergonomics, and postoperative outcomes.
resultsAcross multiple institutions, SP robotic thyroidectomy demonstrated operative times, complication rates, and lymph node yields comparable to those of conventional multi-port or open surgery while providing distinct cosmetic and ergonomic advantages. Transient recurrent laryngeal nerve palsy and hypocalcemia were the most common complications, with low overall morbidity. Recent reports have extended the SP technology to modified radical neck dissection (MRND) through the START, SPRA, and GOSTA approaches, confirming the oncologic feasibility of comprehensive nodal dissection within a confined workspace.
conclusionThe da Vinci SP system represents a meaningful advancement in minimally invasive endocrine surgery by enabling single-port robotic thyroidectomy through various remote-access approaches. Current evidence supports its safety, feasibility, and favorable cosmetic outcomes when applied to appropriately selected patients. However, further refinement of instrumentation, optimization of surgical techniques, and accumulation of long-term clinical data are required to expand its indications and to define its role in advanced thyroid diseases more clearly.
Indexed as
Identifiers
41721029What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.